Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancer

J L Hu1,2,3, G Y He1,2,4, X L Lan1,2,5

  • 1Department of Pathology, Nanfang Hospital, Southern Medical University, 510515, Guangzhou, Guangdong, People's Republic of China.

Oncogenesis
|February 21, 2018
PubMed

Insights

MicroRNA-214 (miR-214) is decreased in colorectal cancer (CRC) after radiation. Restoring miR-214 enhances radiosensitivity by inhibiting autophagy, offering a potential therapeutic target for CRC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colorectal cancer (CRC) treatment is often limited by radioresistance.
  • MicroRNAs (miRNAs) play a role in cellular response to radiation therapy.
  • Understanding radioresistance mechanisms is crucial for improving CRC patient outcomes.

Purpose of the Study:

  • To investigate the role of miR-214 in colorectal cancer radioresistance.
  • To elucidate the molecular mechanisms by which miR-214 affects radiation response in CRC.
  • To identify miR-214 as a potential biomarker and therapeutic target for CRC.

Main Methods:

  • Analysis of miR-214 expression in CRC cell lines and patient samples post-irradiation.
  • Identification of ATG12 as a direct target of miR-214 using dual luciferase assay, qPCR, and Western blot.
  • In vitro and in vivo experiments to assess the effect of miR-214 and ATG12 on radiosensitivity and autophagy.

Main Results:

  • miR-214 levels were decreased in CRC cells and patients after irradiation.
  • Irradiation enhanced autophagy in CRC cells, and ATG12 was identified as a direct target of miR-214.
  • miR-214 overexpression promoted radiosensitivity by inhibiting autophagy, while ATG12 restoration reversed this effect.
  • High miR-214 expression correlated with radiosensitivity and low CEA levels in CRC patients.

Conclusions:

  • miR-214 enhances colorectal cancer radiosensitivity by inhibiting ATG12-mediated autophagy.
  • miR-214 functions as a key regulator of CRC response to irradiation.
  • miR-214 represents a promising therapeutic target for improving colorectal cancer treatment outcomes.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.3K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.8K
Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
111.5K